Developer docs
API playgroundTry for free, no card

Search company profiles

AbbeLight

Full company profile

uuid0003anm

Namestring
AbbeLight
Legal namestring
Abbelight SAS
Websiteurl
abbelight.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Abbelight SAS is a French life-sciences instrumentation company founded in 2016 and headquartered in Cachan (Paris region), that develops and commercializes super-resolution microscopy (nanoscopy) systems based on Single Molecule Localization Microscopy (SMLM). Its flagship SAFe platform is a modular, upgradable bioimaging system compatible with any inverted microscope, offered in four configurations (M45, M90, MN180, MN360) and integrating proprietary ASTER uniform illumination, DAISY detection, DONALD-based Ultimate 3D localization (achieving 15×15×15 nm³ isotropic precision), spectral demixing for simultaneous multi-color SMLM, and the NEO SAFe software suite for acquisition and quantitative analysis. Supporting the platform is a ready-to-use reagent and consumable line (Smart OmniCell Kit, Smart Imaging Kit, Smart Buffer Kit, Smart EVs Kit, Smart Fluorescent Calibration Sample) and tiered Care service plans. The technology was developed over a decade of academic research at CNRS / ISMO / Université Paris-Saclay and ESPCI Paris, and is supported by 90+ scientific publications with impact factors above 13.

Abbelight serves academic and fundamental researchers, biotechnology and pharmaceutical companies, medical facilities, and microbiology researchers, with an installed base of 100+ systems and 200+ users across 4 continents. Revenue is generated through capital equipment sales of the SAFe platform, recurring consumables (sold both via the shop.abbelight.com e-commerce channel and through direct sales), tiered annual Care service subscriptions (Care 1/2/3 and à la carte), NEO software licensing, and à la carte scientific support services. Distribution combines direct enterprise field sales supported by Field Applications Scientists with a global distributor and partner network. The company is privately held, backed by venture and growth equity (most recently a January 2026 Series B led by AVANT BIO) with co-founders Jean-Baptiste Marie (CEO), Nicolas Bourg (CTO), Sandrine Lévêque-Fort (Scientific Advisor), and Emmanuel Fort.

Short descriptiontext

Abbelight SAS is a French life-sciences instrumentation company that develops modular super-resolution microscopy (SMLM nanoscopy) platforms, selling capital equipment, consumable reagent kits, and service plans to academic researchers, biotech, pharmaceutical, and medical-facility laboratories worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCachan, France
HQ citystring
Cachan
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
super-resolution microscopy, single molecule localization, fluorescence bioimaging, nanoscopy platforms, STORM imaging reagents
Industry2 codes
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Optical Instruments & Lenses3827
Product category
Scientific Bioimaging Instrumentation
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1SAFe Platform Hardware Sales
TypeHardware Sales
Description

Modular bioimaging platforms sold in four configurations (SAFe M45, M90, MN180, MN360) designed for different resolution and imaging modality needs. Platforms are adaptable to any inverted microscope and upgradable over time.

abbelight.com
2Reagents and Consumables
TypeHardware Sales
Description

Recurring revenue from ready-to-use reagent kits including Smart OmniCell Kit, Smart Imaging Kit, Smart Buffer Kit, Smart Fluorescent Calibration Sample, and Smart EVs Kit. Consumables ordered through the AbbeLight e-shop.

abbelight.com
3Service Plans (CARE Programs)
TypeSubscription Recurring
Description

Tiered instrument service plans (Care 1, Care 2, Care 3, and à la carte) covering repair parts, labor, travel, on-site assessment, warranty extension, and preventive maintenance. Generates recurring service revenue.

abbelight.com
4Software Licensing
TypeOne Time License
Description

NEO SAFe Software Suite licensed as part of platform configuration or separately for data analysis. Provides acquisition, treatment, and analysis capabilities across all SMLM modalities.

abbelight.com
5Scientific Support Services
TypeProfessional Services
Description

Custom scientific support offered à la carte for specific project assistance including project definition, sample preparation, bioimaging, and data analysis.

abbelight.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Pricing details8 tiers
1Smart OmniCell Kit — all-in-one STORM & DNA-PAINT reagent kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

End-to-end workflow kit from fixation to imaging buffer. Available for purchase online. Custom-packed based on target proteins.

abbelight.com
2Smart Imaging Kit — STORM & DNA-PAINT reagents with validated secondaries
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Complete ready-to-use kit with pre-validated secondary antibodies and optimized buffers. Sold online.

abbelight.com
3Smart Buffer Kit — QC-validated STORM buffer
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Pre-mixed, quality-controlled STORM buffer. Delivery next working day in Europe, 48h in other countries.

abbelight.com
4Smart Fluorescent Calibration Sample — reusable QC standard
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Refillable microfluidic slide for system performance QC. Included in every CARE plan for SAFe owners.

abbelight.com
5AbbeLight Care 1 — Basic service plan
ModelSubscriptionBilling cadenceAnnual
Notes

Covers repair parts, labor, and travel. 24-48 hr response time. One annual on-site preventive maintenance visit.

abbelight.com
6AbbeLight Care 2 — Standard service plan
ModelSubscriptionBilling cadenceAnnual
Notes

Includes all Care 1 benefits plus on-site assessment.

abbelight.com
7AbbeLight Care 3 — Premium service plan
ModelSubscriptionBilling cadenceAnnual
Notes

Includes all Care 2 benefits plus 1-year warranty extension.

abbelight.com
8À la carte Scientific Support
ModelOtherBilling cadenceMulti-year contract
Notes

Custom scientific support for specific projects — quotation upon request.

abbelight.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 11 records shown
1Abbelight SAFe Platform
Description

The Abbelight SAFe (Super-resolution Automated Fluorescence) bioimaging platform is the company's flagship upgradable modular imaging system compatible with all inverted microscopes, supporting fluorescence microscopy and Single Molecule Localization Microscopy (SMLM) up to nanoscale resolution. Includes SAFe Excitation, SAFe Detection, SAFe Nexus, and SAFe Neo Software Suite.

abbelight.com
+10 more records
Core offering1 text field

AbbeLight designs, manufactures, and sells the modular SAFe bioimaging platform that combines advanced fluorescence microscopy with Single Molecule Localization Microscopy (SMLM) for super-resolution imaging down to 15x15x15 nm³ precision. The company also sells ready-to-use reagent kits (Smart OmniCell, Smart Imaging, Smart Buffer, Smart EVs) and the NEO SAFe software suite to provide an end-to-end workflow from sample preparation through quantitative 3D data analysis for life sciences researchers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 30× more data per acquisition compared to conventional SMLM systems due to ASTER uniform large field illumination
+6 more records
Product overview1 text field

AbbeLight offers the SAFe bioimaging platform, a modular system comprising four configurable setups (M45, M90, MN180, MN360) designed for fluorescence microscopy and Single Molecule Localization Microscopy (SMLM). The platform integrates hardware modules (SAFe Excitation, SAFe Detection, SAFe Nexus) with the NEO SAFe Software Suite to deliver end-to-end workflows from sample preparation through quantitative data analysis. Supporting consumables include Smart OmniCell, Smart Imaging, Smart Buffer, and Smart EVs kits, complemented by ASTER uniform illumination and Spectral Demixing technologies. The company also provides service Care Plans and an e-commerce shop for consumables.

Product and service1 record
1Abbelight SAFe Platform
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1CNRS (Centre National de la Recherche Scientifique)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CNRS is France's national research agency and one of the world's most prestigious research organizations. AbbeLight was co-founded based on academic research conducted at CNRS (ISMO laboratory). Ongoing R&D collaboration with CNRS researchers including Sandrine Lévèque-Fort as CNRS Research Director and co-director of GDR ImaBio since 2017.

2ISMO (Institut des Sciences Moléculaires d'Orsay)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ISMO (CNRS / Université Paris-Saclay) is the academic laboratory where AbbeLight's core technology was developed. Nicolas Bourg conducted his PhD in Sandrine Lévêque-Fort's team at ISMO developing the 3D SMLM nanoscope. ISMO researchers continue to collaborate with AbbeLight and appear as co-authors on scientific publications.

abbelight.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Université Paris-Saclay is a major French university and research institution. AbbeLight maintains academic partnerships through this institution, with co-founders having ties to Paris-Saclay through ISMO laboratory.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

ESPCI Paris is a prestigious French engineering school. Emmanuel Fort, co-founder of AbbeLight, is a professor at ESPCI Paris, PSL University, holding the AXA Chair in Biomedical Imaging at the Langevin Institute. Ongoing research collaboration in super-resolution microscopy and wave-matter interactions.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

ONI develops the Nanoimager, a compact, benchtop single-molecule localization microscope (SMLM) targeting the same academic and pharma research customers as AbbeLight. ONI's product overlaps directly on super-resolution imaging and DNA-PAINT workflows, making it the closest stage-comparable direct competitor.

TypeBroad incumbent
Description

Leica's STELLARIS platform with STORM capability is the dominant super-resolution solution sold to pharma and academic core facilities. As part of Danaher, Leica bundles SMLM with broader confocal, light-sheet and EM workflows, making it the largest incumbent competitor in the same product category.

3Carl Zeiss Microscopy
TypeBroad incumbent
Description

Zeiss sells the ELYRA super-resolution system (PALM/SIM/STORM) into academic and pharma research labs. As a broad microscopy incumbent with deep core-facility relationships and large global service infrastructure, Zeiss competes with AbbeLight for high-end imaging budget allocations.

TypeBroad incumbent
Description

Bruker's Vutara super-resolution microscope targets the same single-molecule localization research applications as AbbeLight, particularly in structural biology and cellular biophysics. Bruker's broader AFM and nano-surface portfolio gives it enterprise reach that AbbeLight's narrower platform cannot match.

5Nikon Instruments
TypeBroad incumbent
Description

Nikon's N-STORM and related super-resolution solutions compete in the SMLM/nanoscopy category alongside AbbeLight's SAFe platform. Nikon's large installed base of inverted microscopes and Ti2 systems positions it as an incumbent in core facility purchasing decisions.

TypeDirect peer
Description

LUMICKS develops C-Trap and z-Movi single-molecule fluorescence and biophysics instruments used in pharma drug-discovery and academic research. The product portfolio overlaps with AbbeLight's SMLM-based biophysics use cases, particularly in molecular interaction and mechanistic studies.

TypeEmerging player
Description

PhaseView is a France-based microscopy company offering quantitative phase imaging and super-resolution solutions. Although smaller and earlier-stage than AbbeLight, it competes in the same European academic and research imaging market.

TypeEmerging player
Description

CytoTronics develops Pixelomics, a live-cell, high-throughput electronic imaging platform for cell biology. It represents an emerging alternative approach to high-content cell analysis that could substitute for some SMLM-based phenotyping workflows AbbeLight targets.

TypeOthers
Description

Hamamatsu supplies scientific cameras (Orca, Flash4), detectors and photonics components that are integral to SMLM/nanoscopy systems including AbbeLight's. As a key enabling supplier (and complementary seller of components), it is an ecosystem peer rather than a direct competitor.

TypeOthers
Description

Molecular Devices sells high-content imaging and screening platforms (ImageXpress) used in pharma drug discovery. While not a direct SMLM competitor, it competes for the same pharma screening and phenotyping budgets that AbbeLight is targeting with its single-cell phenotyping expansion.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AbbeLight

Scientific Bioimaging Instrumentationabbelight.com

Abbelight SAS is a French life-sciences instrumentation company that develops modular super-resolution microscopy (SMLM nanoscopy) platforms, selling capital equipment, consumable reagent kits, and service plans to academic researchers, biotech, pharmaceutical, and medical-facility laboratories worldwide.

What AbbeLight does

Abbelight SAS is a French life-sciences instrumentation company founded in 2016 and headquartered in Cachan (Paris region), that develops and commercializes super-resolution microscopy (nanoscopy) systems based on Single Molecule Localization Microscopy (SMLM). Its flagship SAFe platform is a modular, upgradable bioimaging system compatible with any inverted microscope, offered in four configurations (M45, M90, MN180, MN360) and integrating proprietary ASTER uniform illumination, DAISY detection, DONALD-based Ultimate 3D localization (achieving 15×15×15 nm³ isotropic precision), spectral demixing for simultaneous multi-color SMLM, and the NEO SAFe software suite for acquisition and quantitative analysis. Supporting the platform is a ready-to-use reagent and consumable line (Smart OmniCell Kit, Smart Imaging Kit, Smart Buffer Kit, Smart EVs Kit, Smart Fluorescent Calibration Sample) and tiered Care service plans. The technology was developed over a decade of academic research at CNRS / ISMO / Université Paris-Saclay and ESPCI Paris, and is supported by 90+ scientific publications with impact factors above 13.

Abbelight serves academic and fundamental researchers, biotechnology and pharmaceutical companies, medical facilities, and microbiology researchers, with an installed base of 100+ systems and 200+ users across 4 continents. Revenue is generated through capital equipment sales of the SAFe platform, recurring consumables (sold both via the shop.abbelight.com e-commerce channel and through direct sales), tiered annual Care service subscriptions (Care 1/2/3 and à la carte), NEO software licensing, and à la carte scientific support services. Distribution combines direct enterprise field sales supported by Field Applications Scientists with a global distributor and partner network. The company is privately held, backed by venture and growth equity (most recently a January 2026 Series B led by AVANT BIO) with co-founders Jean-Baptiste Marie (CEO), Nicolas Bourg (CTO), Sandrine Lévêque-Fort (Scientific Advisor), and Emmanuel Fort.

AbbeLight firmographics

Firmographics
Name
AbbeLight
Legal name
Abbelight SAS
Website
https://abbelight.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
51–100 employees
Short description
Abbelight SAS is a French life-sciences instrumentation company that develops modular super-resolution microscopy (SMLM nanoscopy) platforms, selling capital equipment, consumable reagent kits, and service plans to academic researchers, biotech, pharmaceutical, and medical-facility laboratories worldwide.
Ownership category
akta.pro rank

AbbeLight industry classification

Industry
Product category
Scientific Bioimaging Instrumentation
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Laboratory Analytical Instruments (3826), Optical Instruments & Lenses (3827)
akta.pro industry
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Super-resolution microscopy
  • Single molecule localization
  • Fluorescence bioimaging
  • Nanoscopy platforms
  • STORM imaging reagents

Where AbbeLight is headquartered

Location

Headquarters

HQ city
Cachan
HQ country
France
HQ region
Europe

Offices2 records

Markets served

AbbeLight business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. SAFe Platform Hardware Sales: Modular bioimaging platforms sold in four configurations (SAFe M45, M90, MN180, MN360) designed for different resolution and imaging modality needs. Platforms are adaptable to any inverted microscope and upgradable over time.
  2. Reagents and Consumables: Recurring revenue from ready-to-use reagent kits including Smart OmniCell Kit, Smart Imaging Kit, Smart Buffer Kit, Smart Fluorescent Calibration Sample, and Smart EVs Kit. Consumables ordered through the AbbeLight e-shop.
  3. Service Plans (CARE Programs): Tiered instrument service plans (Care 1, Care 2, Care 3, and à la carte) covering repair parts, labor, travel, on-site assessment, warranty extension, and preventive maintenance. Generates recurring service revenue.
  4. Software Licensing: NEO SAFe Software Suite licensed as part of platform configuration or separately for data analysis. Provides acquisition, treatment, and analysis capabilities across all SMLM modalities.
  5. Scientific Support Services: Custom scientific support offered à la carte for specific project assistance including project definition, sample preparation, bioimaging, and data analysis.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goSmart OmniCell Kit — all-in-one STORM & DNA-PAINT reagent kit
Unit PricingPay-as-you-goSmart Imaging Kit — STORM & DNA-PAINT reagents with validated secondaries
Unit PricingPay-as-you-goSmart Buffer Kit — QC-validated STORM buffer
Unit PricingPay-as-you-goSmart Fluorescent Calibration Sample — reusable QC standard
SubscriptionAnnualAbbeLight Care 1 — Basic service plan
SubscriptionAnnualAbbeLight Care 2 — Standard service plan
SubscriptionAnnualAbbeLight Care 3 — Premium service plan
OtherMulti-year contractÀ la carte Scientific Support

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

AbbeLight product offering

Product offering

Core offering

AbbeLight designs, manufactures, and sells the modular SAFe bioimaging platform that combines advanced fluorescence microscopy with Single Molecule Localization Microscopy (SMLM) for super-resolution imaging down to 15x15x15 nm³ precision. The company also sells ready-to-use reagent kits (Smart OmniCell, Smart Imaging, Smart Buffer, Smart EVs) and the NEO SAFe software suite to provide an end-to-end workflow from sample preparation through quantitative 3D data analysis for life sciences researchers.

Product overview

AbbeLight offers the SAFe bioimaging platform, a modular system comprising four configurable setups (M45, M90, MN180, MN360) designed for fluorescence microscopy and Single Molecule Localization Microscopy (SMLM). The platform integrates hardware modules (SAFe Excitation, SAFe Detection, SAFe Nexus) with the NEO SAFe Software Suite to deliver end-to-end workflows from sample preparation through quantitative data analysis. Supporting consumables include Smart OmniCell, Smart Imaging, Smart Buffer, and Smart EVs kits, complemented by ASTER uniform illumination and Spectral Demixing technologies. The company also provides service Care Plans and an e-commerce shop for consumables.

Differentiator

Problem solved

Functional benefit

Brands

  • Abbelight SAFe Platform: The Abbelight SAFe (Super-resolution Automated Fluorescence) bioimaging platform is the company's flagship upgradable modular imaging system compatible with all inverted microscopes, supporting fluorescence microscopy and Single Molecule Localization Microscopy (SMLM) up to nanoscale resolution. Includes SAFe Excitation, SAFe Detection, SAFe Nexus, and SAFe Neo Software Suite.
  • Abbelight Smart Flow
  • Abbelight SAFe Neo Software Suite
  • Smart OmniCell Kit
  • Smart Imaging Kit
  • Smart Buffer Kit
  • Smart Fluorescent Calibration Sample
  • SAFe M45
  • SAFe M90
  • SAFe MN180
  • SAFe MN360

Products and services

  • Abbelight SAFe Platform

Quantifiable outcome

  • 30× more data per acquisition compared to conventional SMLM systems due to ASTER uniform large field illumination
  • +6 more outcomes

Companies that use AbbeLight

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

AbbeLight technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature8 records

AbbeLight partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • CNRS (Centre National de la Recherche Scientifique)coreStrategic or Co-development PartnerCNRS is France's national research agency and one of the world's most prestigious research organizations. AbbeLight was co-founded based on academic research conducted at CNRS (ISMO laboratory). Ongoing R&D collaboration with CNRS researchers including Sandrine Lévèque-Fort as CNRS Research Director and co-director of GDR ImaBio since 2017.
  • ISMO (Institut des Sciences Moléculaires d'Orsay)coreStrategic or Co-development PartnerISMO (CNRS / Université Paris-Saclay) is the academic laboratory where AbbeLight's core technology was developed. Nicolas Bourg conducted his PhD in Sandrine Lévêque-Fort's team at ISMO developing the 3D SMLM nanoscope. ISMO researchers continue to collaborate with AbbeLight and appear as co-authors on scientific publications.
  • Université Paris-SaclaycoreStrategic or Co-development PartnerUniversité Paris-Saclay is a major French university and research institution. AbbeLight maintains academic partnerships through this institution, with co-founders having ties to Paris-Saclay through ISMO laboratory.
  • ESPCI Paris (École Supérieure de Physique et de Chimie Industrielles)coreStrategic or Co-development PartnerESPCI Paris is a prestigious French engineering school. Emmanuel Fort, co-founder of AbbeLight, is a professor at ESPCI Paris, PSL University, holding the AXA Chair in Biomedical Imaging at the Langevin Institute. Ongoing research collaboration in super-resolution microscopy and wave-matter interactions.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

AbbeLight competitors and assessment

Company assessment

Direct peers

  • Oxford Nanoimaging (ONI): ONI develops the Nanoimager, a compact, benchtop single-molecule localization microscope (SMLM) targeting the same academic and pharma research customers as AbbeLight. ONI's product overlaps directly on super-resolution imaging and DNA-PAINT workflows, making it the closest stage-comparable direct competitor.
  • LUMICKS: LUMICKS develops C-Trap and z-Movi single-molecule fluorescence and biophysics instruments used in pharma drug-discovery and academic research. The product portfolio overlaps with AbbeLight's SMLM-based biophysics use cases, particularly in molecular interaction and mechanistic studies.

Broad incumbents

  • Leica Microsystems (Danaher): Leica's STELLARIS platform with STORM capability is the dominant super-resolution solution sold to pharma and academic core facilities. As part of Danaher, Leica bundles SMLM with broader confocal, light-sheet and EM workflows, making it the largest incumbent competitor in the same product category.
  • Carl Zeiss Microscopy: Zeiss sells the ELYRA super-resolution system (PALM/SIM/STORM) into academic and pharma research labs. As a broad microscopy incumbent with deep core-facility relationships and large global service infrastructure, Zeiss competes with AbbeLight for high-end imaging budget allocations.
  • Bruker Nano Surfaces: Bruker's Vutara super-resolution microscope targets the same single-molecule localization research applications as AbbeLight, particularly in structural biology and cellular biophysics. Bruker's broader AFM and nano-surface portfolio gives it enterprise reach that AbbeLight's narrower platform cannot match.
  • Nikon Instruments: Nikon's N-STORM and related super-resolution solutions compete in the SMLM/nanoscopy category alongside AbbeLight's SAFe platform. Nikon's large installed base of inverted microscopes and Ti2 systems positions it as an incumbent in core facility purchasing decisions.

Emerging players

  • PhaseView: PhaseView is a France-based microscopy company offering quantitative phase imaging and super-resolution solutions. Although smaller and earlier-stage than AbbeLight, it competes in the same European academic and research imaging market.
  • CytoTronics: CytoTronics develops Pixelomics, a live-cell, high-throughput electronic imaging platform for cell biology. It represents an emerging alternative approach to high-content cell analysis that could substitute for some SMLM-based phenotyping workflows AbbeLight targets.

Others

  • Hamamatsu Photonics: Hamamatsu supplies scientific cameras (Orca, Flash4), detectors and photonics components that are integral to SMLM/nanoscopy systems including AbbeLight's. As a key enabling supplier (and complementary seller of components), it is an ecosystem peer rather than a direct competitor.
  • Molecular Devices (Danaher): Molecular Devices sells high-content imaging and screening platforms (ImageXpress) used in pharma drug discovery. While not a direct SMLM competitor, it competes for the same pharma screening and phenotyping budgets that AbbeLight is targeting with its single-cell phenotyping expansion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

AbbeLight social profiles

Digital presence

AbbeLight financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AbbeLight leadership team

Management profile

Number of profiles

Profiles7 records

AbbeLight funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AbbeLight M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AbbeLight

What does AbbeLight do?

AbbeLight designs, manufactures, and sells the modular SAFe bioimaging platform that combines advanced fluorescence microscopy with Single Molecule Localization Microscopy (SMLM) for super-resolution imaging down to 15x15x15 nm³ precision. The company also sells ready-to-use reagent kits (Smart OmniCell, Smart Imaging, Smart Buffer, Smart EVs) and the NEO SAFe software suite to provide an end-to-end workflow from sample preparation through quantitative 3D data analysis for life sciences researchers.

Is AbbeLight a public or private company?

AbbeLight is a private company. It is classified as venture growth investor backed and is currently operating.

When was AbbeLight founded?

AbbeLight was founded in 2016. It employs 51 to 100 people.

Where is AbbeLight based?

AbbeLight is headquartered in Cachan, France, in the Europe region.

How does AbbeLight make money?

Five revenue lines are on record. SAFe Platform Hardware Sales are the primary driver. The others are reagents and Consumables, service Plans (CARE Programs), software Licensing and scientific Support Services.

Who are AbbeLight's main competitors?

Direct peers on record are Oxford Nanoimaging (ONI) and LUMICKS. Broad incumbents are Leica Microsystems (Danaher), Carl Zeiss Microscopy, Bruker Nano Surfaces and Nikon Instruments. Emerging players are PhaseView and CytoTronics. Others are Hamamatsu Photonics and Molecular Devices (Danaher).

Does AbbeLight have an API?

No public API is recorded for AbbeLight.

What industry is AbbeLight in?

AbbeLight's product category is Scientific Bioimaging Instrumentation. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Abbelight: Series B Raised To Expand Super-Resolution Microscopy AdoptionAbbelight closed a Series B financing round led by AVANT BIO to accelerate product innovation and broaden commercial adoption of its super-resolution microscopy solutions. The funding will support commercial expansion and customer support as the company scales beyond its existing installed base of over 100 systems.BioSpaceAbbelight Announces Successful Series B Investment led by AVANT BIO to Accelerate Imaging Innovation and Scale Adoption Across a Broader Customer BaseAbbelight, a Paris-based global leader in super-resolution microscopy solutions, announced a successful Series B financing round led by growth equity firm AVANT BIO. The funding will accelerate Abbelight's commercial expansion into new verticals including single cell phenotyping and drug discovery mechanisms of action validation, while supporting its existing 100+ customer installed base. AVANT BIO, which focuses on enabling technologies shaping tomorrow's therapeutics, stated the investment is engineered to unlock value and accelerate growth in therapeutic enabling technologies, TechBio, and HealthTech.AijournAbbelight Announces Successful Series B Investment led by AVANT BIO to Accelerate Imaging Innovation and Scale Adoption Across a Broader Customer BaseAbbelight, a Paris-based pioneer in super-resolution microscopy solutions, announced the successful completion of a Series B financing round led by growth equity firm AVANT BIO. The funding will accelerate Abbelight's commercial expansion and enable development of its imaging technology for new verticals including single cell phenotyping and drug discovery applications for biopharma, biotech, and CROs. Founded in 2016, Abbelight currently employs approximately 60 people and serves a global installed base of over 100 customers.Business Wire BlogAbbelight Announces Successful Series B Investment led by AVANT BIO to Accelerate Imaging Innovation and Scale Adoption Across a Broader Customer BaseAbbelight, a Paris-based pioneer in super-resolution microscopy solutions, announced the successful completion of a Series B financing round led by AVANT BIO, a growth equity firm focused on enabling technologies for therapeutics development. The funding will support the company's commercial expansion and accelerate adoption of its imaging technology across new verticals including single cell phenotyping and drug discovery applications. The investment is expected to strengthen Abbelight's position in the bioindustry market, serving biopharma, biotech, and contract research organizations.AbbelightAbbelight Announces Successful Series B Investment led by AVANT BIO to accelerate imaging innovation and scale adoption across a broader customer base.Abbelight, a Paris-based pioneer in super-resolution microscopy and nanoscopy (SMLM) solutions, announced successful completion of a Series B financing round led by growth equity firm AVANT BIO. The funding will be used to accelerate imaging innovation, expand into new verticals such as single cell phenotyping and drug discovery mechanisms of action validation, and scale commercial adoption across the broader bioindustry including biopharma, biotech, and CROs. The company, which employs approximately 60 people and serves over 100 installed customers, positioned the investment as key to driving innovation and adoption across life sciences.FinSMEsAbbelight Raises Series B FundingAbbelight, a Paris-based provider of high-resolution microscopy and nanoscopy (SMLM) solutions, has closed a Series B financing round led by AVANT BIO with the amount remaining undisclosed. Founded in 2016, the company offers end-to-end solutions incorporating chemistry, optics, and data analysis that enable researchers at public institutes and biotech companies to study biological mechanisms at the nanoscale. Abbelight currently employs approximately 60 people.Odysseeventuremicroscopes à super-résolutionAbbelight has developed innovative solutions in super-resolution microscopy since its founding in 2016, recently achieving a significant milestone with the sale of over 50 devices, generating approximately 10 million euros in revenue. In 2024, the company plans to establish a joint laboratory with CNRS and the University of Paris-Saclay as part of its expansion strategy. The technology enables optical microscopes to achieve molecular-level resolution, enhancing research capabilities.